Apronal

Apronal
Clinical data
Routes of
administration
Oral
ATC code N05CM12 (WHO)
Pharmacokinetic data
Excretion Renal
Identifiers
CAS Number 528-92-7 YesY
PubChem (CID) 10715
ChemSpider 10264 YesY
UNII V18J24E25E YesY
KEGG D03975 YesY
ChEMBL CHEMBL509282 YesY
Chemical and physical data
Formula C9H16N2O2
Molar mass 184.236 g/mol
3D model (Jmol) Interactive image
Chirality Racemic mixture
  (verify)

Apronal (brand name Sedormid), or apronalide, also known as allylisopropylacetylurea or allylisopropylacetylcarbamide, is a hypnotic/sedative drug of the ureide (acylurea) group synthesized in 1926[1] by Hoffmann-La Roche that is no longer used. Though it is not a barbiturate, apronalide is similar in structure to the barbiturates (being an open-chain carbamide instead of having a heterocyclic ring).[2] In accordance, it is similar in action to the barbiturates, although considerably milder in comparison (formerly used as a daytime sedative at doses of 1 to 2 grams every 3 to 4 hours).[2] Upon the finding that it caused patients to develop thrombocytopenic purpura, apronalide was withdrawn from clinical use.[3]

See also

References

  1. DE Patent 459903 - Verfahren zur Darstellung von Ureiden der Dialkylessigsaeuren
  2. 1 2 Roche Review ... Hoffman-La Roche, and Roche-organon. 1938. p. 164.
  3. R. L. Vollum; D. G. Jamison; C. S. Cummins (20 May 2014). Fairbrother's Textbook of Bacteriology. Elsevier Science. pp. 152–. ISBN 978-1-4831-4178-7.



This article is issued from Wikipedia - version of the 10/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.